AA
PAHC icon

ALPS Advisors’s Phibro Animal Health PAHC Stock Holding History

ALPS Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Buy
10,131
+121
+1% +$5.11K ﹤0.01% 1078
2026
Q1 		$554K Buy
+10,010
New +$476K ﹤0.01% 684
2018
Q1 		– Sell
-12,873
Closed -$431K – 962
2017
Q4 		$431K Hold
12,873
– – ﹤0.01% 663
2017
Q3 		$477K Sell
12,873
-4,668
-27% -$175K ﹤0.01% 609
2017
Q2 		$650K Buy
17,541
+46
+0.3% +$1.5K ﹤0.01% 318
2017
Q1 		$492K Sell
17,495
-50
-0.3% -$1.41K ﹤0.01% 460
2016
Q4 		$514K Buy
17,545
+973
+6% +$26.6K ﹤0.01% 376
2016
Q3 		$450K Sell
16,572
-248
-1% -$5.61K ﹤0.01% 337
2016
Q2 		$314K Sell
16,820
-500
-3% -$10.4K ﹤0.01% 567
2016
Q1 		$468K Buy
+17,320
New +$497K ﹤0.01% 280

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ALPS Advisors's PAHC Position: Q2 2026 in Review

ALPS Advisors increased its Phibro Animal Health (PAHC) stake by 1.2% in Q2 2026, buying an estimated $5.11K and bringing the position to 10,131 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

ALPS Advisors first reported a position in PAHC in Q1 2016 and has held it in 10 quarters since. The position peaked at $650K in Q2 2017. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • ALPS Advisors held 10,131 shares of Phibro Animal Health worth $318K as of Q2 2026.
  • ALPS Advisors bought 121 Phibro Animal Health shares in Q2 2026, an estimated $5.11K.
  • Phibro Animal Health made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1078 holding.
  • ALPS Advisors first reported a position in Phibro Animal Health in Q1 2016 and has held it in 10 quarters since.
  • ALPS Advisors's Phibro Animal Health position peaked at $650K in Q2 2017.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.